Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LLY | NVO | JNJ | ||
| Company | Eli Lilly and Company | Novo Nordisk A/S ADR | Johnson & Johnson | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 723.48 | 126.15 | 146.70 | ||
| High | 737.45 | 127.90 | 147.18 | ||
| Low | 721.00 | 125.99 | 145.95 | ||
| Last | 733.51 | 126.85 | 146.14 | ||
| Change | +8.64 | +1.06 | -0.68 | ||
| % Change | +1.19% | +0.84% | -0.46% | ||
| Volume | 2,009,200 | 3,312,400 | 6,182,900 | ||
| 20-Day Average Volume | 2,365,835 | 3,472,985 | 8,037,735 | ||
| Previous Close | 724.87 | 125.79 | 146.82 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 752.43 | 125.40 | 149.78 | ||
| 20-Day Raw Stochastic | 21.85% | 69.13% | 20.04% | ||
| 20-Day Relative Strength | 45.82% | 52.94% | 35.08% | ||
| Weighted Alpha | +76.91 | +55.70 | -12.51 | ||
| Today's Opinion | 40% Buy | 72% Buy | 100% Sell | ||
| Previous Opinion | 40% Buy | 56% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.99% since 04/19/24 | +3.37% since 04/19/24 | -1.20% since 04/19/24 | ||
| Low | 718.30 on 04/25/24 | 122.57 on 04/22/24 | 145.95 on 04/26/24 | ||
| High | 752.64 on 04/24/24 | 128.76 on 04/23/24 | 150.49 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -5.34% since 03/26/24 | -1.98% since 03/26/24 | -6.18% since 03/26/24 | ||
| Low | 718.30 on 04/25/24 | 121.79 on 04/16/24 | 143.13 on 04/18/24 | ||
| High | 793.67 on 03/28/24 | 130.16 on 03/28/24 | 159.14 on 03/28/24 | ||
| 3-Month | |||||
| %Chg | +14.75% since 01/26/24 | +17.38% since 01/26/24 | -8.38% since 01/26/24 | ||
| Low | 637.00 on 01/31/24 | 107.70 on 01/29/24 | 143.13 on 04/18/24 | ||
| High | 800.78 on 03/04/24 | 138.28 on 03/07/24 | 163.11 on 03/12/24 | ||
| 6-Month | |||||
| %Chg | +29.12% since 10/26/23 | +33.25% since 10/26/23 | -1.92% since 10/26/23 | ||
| Low | 547.61 on 10/31/23 | 92.94 on 10/27/23 | 143.13 on 04/18/24 | ||
| High | 800.78 on 03/04/24 | 138.28 on 03/07/24 | 163.58 on 01/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 688,745,344 | 564,486,656 | 353,804,352 | ||
| Shares Outstanding, K | 950,164 | 4,487,532 | 2,409,783 | ||
| Annual Sales | 34,124,100,000 | 33,724,300,000 | 85,159,000,000 | ||
| Annual Net Income | 5,240,400,000 | 12,150,770,000 | 35,153,000,000 | ||
| Last Quarter Sales | 9,353,400,000 | 9,526,160,000 | 21,383,000,000 | ||
| Last Quarter Net Income | 2,189,700,000 | 3,175,360,000 | 5,354,000,000 | ||
| 60-Month Beta | 0.34 | 0.41 | 0.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.49 on 02/06/24 | 0.71 on 01/31/24 | 2.71 on 04/16/24 | ||
| Latest Earnings Date | 04/30/24 | 05/02/24 | 04/16/24 | ||
| Most Recent Dividend | 1.300 on 02/14/24 | 0.663 on 03/22/24 | 1.190 on 02/16/24 | ||
| Next Ex-Dividends Date | 02/14/24 | 03/22/24 | 05/20/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 115.85 | 46.64 | 14.20 | ||